Spain vs Turkmenistan: Treatment success rate for patients treated for MDR-TB
Spain
71.0%
in 2022
Turkmenistan
71.0%
in 2022
Spain rank
91st
Turkmenistan rank
91st
Treatment success rate for patients treated for MDR-TB over time
- Spain
- Turkmenistan
How they compare
Spain currently reports 71.0% against 71.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2015 it was Turkmenistan ahead.
Spain ranks 91st and Turkmenistan ranks 91st of 163 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Spain | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39.4% | 57.6% | 18.2% | Turkmenistan |
| 2020s | 65.3% | 67.3% | 2.0% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Spain or Turkmenistan?
- Spain, at 71.0% against 71.0% in Turkmenistan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Spain and Turkmenistan?
- 0.0%, with Spain ahead.
- How many years of comparable data are there for Spain and Turkmenistan?
- 8 years are reported by both, from 2015 to 2022.
- How do Spain and Turkmenistan rank globally for treatment success rate for patients treated for mdr-tb?
- Spain ranks 91st and Turkmenistan ranks 91st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.